Pursuant to Regulation 24A of SEBI Listing Regulations read with SEBI Circular no. CIR/CFD/CMD7 27l2ol9 dated 8th February, 2019, Sudarshan Pharma Industries has enclosed the Annual Secretarial Compliance Report issued by Vishal Manseta, Company Secretary in Practice, for the financial year ended 31st March 2026.
The above information is a part of company’s filings submitted to BSE.